Azadpour Motlagh Asieh, Dolatian Mahrokh, Mojab Faraze, Nasiri Malihe, Ezatpour Behrouz, Sahranavard Yadollah, Shakiba Heshmat, Rahimy Bahram, Ghanati Kiandokht
International Branch of Shahid Beheshti, University of Medical Sciences, Tehran, Iran.
Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Int J Community Based Nurs Midwifery. 2018 Apr;6(2):100-110.
The present study was conducted on the effect of prangos ferulacea vaginal cream on accelerating the recovery of bacterial vaginosis.
This randomized controlled clinical trial was conducted on 100 non-pregnant women referring to health centers affiliated to Lorestan University of Medical Sciences in 2016 with the diagnosis of bacterial vaginosis based on the patient's complaints, Amsel's clinical criteria, and the Nugent microscopic criteria. The women were randomly divided into two groups of 50. One group was treated with oral metronidazole plus Prangos ferulacea vaginal cream and the other with oral metronidazole plus a placebo vaginal cream for seven days. The patient's complaints, Amsel's clinical criteria and the Nugent microscopic criteria were assessed seven days after treatment. The data were analyzed using SPSS, version 20, with a significance level of 0.05.
The response to oral metronidazole plus Prangos ferulacea vaginal cream treatment was 94% according to Amsel's clinical criteria and 88% according to the Nugent microscopic criteria. The response to oral metronidazole plus placebo vaginal cream treatment was 94% according to Amsel's criteria and 86% according to the Nugent criteria. The analysis of the patients' complaints, Amsel's clinical criteria and the Nugent microscopic criteria showed significant differences in each group before and after the treatment.
This trial showed that Prangos ferulacea vaginal cream accelerated the recovery of bacterial vaginosis of patients with bacterial vaginosis. It can be used effectively as a complementary treatment with oral metronidazole in cases of medication resistance and also in people wishing to use herbal remedies IRCT2016042327534N1.
本研究旨在探讨阿魏阴道乳膏对加速细菌性阴道病康复的作用。
本随机对照临床试验于2016年对100名非妊娠女性进行,这些女性因细菌性阴道病症状、阿姆斯尔临床标准及纽金特显微镜标准,前往洛雷斯坦医科大学附属健康中心就诊。将这些女性随机分为两组,每组50人。一组接受口服甲硝唑加阿魏阴道乳膏治疗,另一组接受口服甲硝唑加安慰剂阴道乳膏治疗,为期7天。治疗7天后评估患者症状、阿姆斯尔临床标准及纽金特显微镜标准。数据采用SPSS 20.0软件进行分析,显著性水平设定为0.05。
根据阿姆斯尔临床标准,口服甲硝唑加阿魏阴道乳膏治疗的有效率为94%,根据纽金特显微镜标准为88%。根据阿姆斯尔标准,口服甲硝唑加安慰剂阴道乳膏治疗的有效率为94%,根据纽金特标准为86%。对患者症状、阿姆斯尔临床标准及纽金特显微镜标准的分析显示,每组治疗前后均有显著差异。
本试验表明,阿魏阴道乳膏可加速细菌性阴道病患者的康复。在耐药病例中,它可与口服甲硝唑有效联合使用,也适用于希望使用草药疗法的人群(IRCT2016042327534N1)。